Peptides for Longevity: The Evidence Behind Epitalon, MOTS-c, and Hayflick Claims
Bottom line Peptides marketed for longevity, such as Epitalon and MOTS-c, currently lack strong human data or are unavailable to consumers, with stronger evidence for slowing aging biomarkers coming from non-peptide interventions. Hype vs. Reality: Epitalon, a highly publicized longevity peptide, has weak human data. Availability: MOTS-c, a scientifically interesting peptide, is not sold to […]
Peptides for Longevity: The Evidence Behind Epitalon, MOTS-c, and Hayflick Claims Read More »









